​

Agenus (AGEN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AGEN Stock Forecast

Agenus (AGEN) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $7.00, with a high of $7.00 and a low of $7.00. This represents a 93.91% increase from the last price of $3.61.

- $4 $8 $12 $16 $20 High: $7 Avg: $7 Low: $7 Last Closed Price: $3.61

AGEN Stock Rating

Agenus stock's rating consensus is Hold, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (25.00%), 3 Hold (75.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 4 0 3 1 Strong Sell Sell Hold Buy Strong Buy

AGEN Forecast vs Benchmarks

TypeNameUpside
StockAgenus93.91%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts-15
Avg Price Target-$7.00$10.20
Last Closing Price$3.61$3.61$3.61
Upside/Downside-93.91%182.55%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-14--5
Dec, 24-14--5
Nov, 24214--7
Oct, 24214--7
Sep, 24214--7
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 29, 2024Emily BodnarH.C. Wainwright$7.00$3.5796.08%93.91%
Jul 19, 2024Biren AminJefferies$7.00$5.9916.86%93.91%
Jul 19, 2024Colleen KusyRobert W. Baird$8.00$7.309.59%121.61%
Jul 18, 2024Emily BodnarH.C. Wainwright$9.00$7.9812.78%149.31%
Jul 01, 2024Emily BodnarH.C. Wainwright$20.00$8.38138.66%454.02%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Nov 29, 2024H.C. WainwrightNeutralNeutralhold
Aug 14, 2024B. RileyBuyBuyhold
Jul 19, 2024JefferiesHolddowngrade
Jul 18, 2024William BlairMarket Performdowngrade
Jul 18, 2024H.C. WainwrightBuyNeutraldowngrade
Jul 01, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-35 $-28 $-21 $-14 $-7 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.39$-0.41$-0.96$-0.69-----
Avg Forecast$-21.07$-0.74$-14.85$-12.50$-12.02$-7.19$-4.77$-5.89$-4.45
High Forecast$-34.79$-1.22$-24.02$-14.88$-14.27$-9.66$-7.85$-7.81$-7.74
Low Forecast$-14.96$-0.52$-9.73$-10.12$-9.75$-4.50$-1.96$-2.60$-2.45
Surprise %-93.40%-44.59%-93.54%-94.48%-----

Revenue Forecast

$50M $140M $230M $320M $410M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$88.17M$295.67M$98.02M$156.31M-----
Avg Forecast$74.60M$313.14M$82.52M$118.94M$106.42M$134.11M$120.49M$125.00M$267.45M
High Forecast$57.96M$243.28M$60.63M$92.32M$96.09M$78.32M$118.44M$81.86M$175.14M
Low Forecast$111.98M$470.05M$121.71M$137.79M$116.87M$187.22M$122.54M$196.07M$419.51M
Surprise %18.19%-5.58%18.79%31.42%-----

Net Income Forecast

$-650M $-520M $-390M $-260M $-130M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-240.13M$-94.70M$-271.51M$-257.44M-----
Avg Forecast$-376.95M$-13.17M$-47.87M$-245.97M$-227.86M$-126.76M$-87.84M$-93.15M$-79.63M
High Forecast$-622.51M$-21.75M$-94.17M$-426.95M$-255.42M$-172.93M$-140.54M$-139.81M$-138.49M
Low Forecast$-267.63M$-9.35M$-1.57M$-65.00M$-174.52M$-80.59M$-35.14M$-46.49M$-43.90M
Surprise %-36.30%619.03%467.23%4.66%-----

AGEN Forecast FAQ

Is Agenus stock a buy?

Agenus stock has a consensus rating of Hold, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Agenus is a neutral investment for most analysts.

What is Agenus's price target?

Agenus's price target, set by 4 Wall Street analysts, averages $7 over the next 12 months. The price target range spans from $7 at the low end to $7 at the high end, suggesting a potential 93.91% change from the previous close price of $3.61.

How does Agenus stock forecast compare to the average forecast of its sector, industry, and investment themes?

Agenus stock forecast shows a 93.91% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Agenus over the past three months?

  • January 2025: 0% Strong Buy, 20.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 20.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 28.57% Strong Buy, 14.29% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.

What is Agenus’s EPS forecast?

Agenus's average annual EPS forecast for its fiscal year ending in December is -12.02 for 2024, a 1642.03% increase from the reported $-0.69 in 2023. The prediction for 2025 is $-7.19, $-4.77 for 2026, $-5.89 for 2027, and $-4.45 for 2028.

What is Agenus’s revenue forecast?

Agenus's average annual revenue forecast for its fiscal year ending in December is $106.42M for 2024, a -31.92% decrease from the reported $156.31M in 2023. The forecast for 2025 is $134.11M, $120.49M for 2026, $125M for 2027, and $267.45M for 2028.

What is Agenus’s net income forecast?

For its fiscal year ending in December, Agenus's average annual net income forecast is $-228M for 2024, reflecting a -11.49% decrease from the reported $-257M in 2023. The projection for 2025 is $-127M, $-87.839M for 2026, $-93.151M for 2027, and $-79.63M for 2028.